Home » Pending Appeals Court Case Could Shift FDA’s Guidance Policy, Attorneys Say
Pending Appeals Court Case Could Shift FDA’s Guidance Policy, Attorneys Say
Drugmakers dissatisfied with the FDA’s use of guidances as a form of policymaking could find relief with a case pending appeal in the U.S. Court of Appeals for the Eleventh Circuit, industry attorneys tell DID.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May